drugset / Trial / NCT04056481
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
Summary
The purpose of this study is to provide expanded access of givosiran to patients with Acute Hepatic Porphyria (AHP).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Givosiran | Small interfering RNA (siRNA) | — | Subcutaneous |